Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3678001013 | Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3678002018 | Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3678003011 | Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | est un(e) (attribut) | Product containing only dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Plays role | Digestant therapeutic role (role) | true | Inferred relationship | Some | ||
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | est un(e) (attribut) | Product containing dehydrocholic acid (medicinal product) | false | Inferred relationship | Some | ||
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | est un(e) (attribut) | pancréatine | false | Inferred relationship | Some | ||
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | a pour principe actif (attribut) | Pancreatin (substance) | false | Inferred relationship | Some | ||
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | a pour principe actif (attribut) | Dehydrocholic acid (substance) | false | Inferred relationship | Some | ||
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | a pour principe actif (attribut) | Bile | false | Inferred relationship | Some | ||
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | est un(e) (attribut) | Product containing simeticone (medicinal product) | false | Inferred relationship | Some | ||
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | a pour principe actif (attribut) | Simethicone | false | Inferred relationship | Some | ||
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | a une forme pharmaceutique (attribut) | comprimé | false | Inferred relationship | Some | ||
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | a une forme pharmaceutique (attribut) | Oral tablet | true | Inferred relationship | Some | ||
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | est un(e) (attribut) | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | a pour principe actif (attribut) | Simethicone | false | Inferred relationship | Some | 1 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has basis of strength substance (attribute) | Simethicone | false | Inferred relationship | Some | 1 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has presentation strength numerator value (attribute) | 40 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | a pour principe actif (attribut) | Pancreatin (substance) | false | Inferred relationship | Some | 2 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has basis of strength substance (attribute) | Pancreatin (substance) | false | Inferred relationship | Some | 2 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has presentation strength numerator value (attribute) | 300 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 2 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | a pour principe actif (attribut) | Dehydrocholic acid (substance) | false | Inferred relationship | Some | 3 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has basis of strength substance (attribute) | Dehydrocholic acid (substance) | false | Inferred relationship | Some | 3 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has presentation strength numerator value (attribute) | 180 (qualifier value) | false | Inferred relationship | Some | 3 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 3 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has presentation strength denominator value | un | false | Inferred relationship | Some | 3 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 3 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has basis of strength substance (attribute) | Pancreatin (substance) | true | Inferred relationship | Some | 1 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has presentation strength numerator value (attribute) | 300 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has basis of strength substance (attribute) | Dehydrocholic acid (substance) | true | Inferred relationship | Some | 2 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has presentation strength numerator value (attribute) | 180 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has basis of strength substance (attribute) | Simethicone | true | Inferred relationship | Some | 3 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has presentation strength numerator value (attribute) | 40 (qualifier value) | false | Inferred relationship | Some | 3 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has precise active ingredient | Simethicone | true | Inferred relationship | Some | 3 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | est un(e) (attribut) | Dehydrocholic acid- and pancreatin- and simethicone-containing product in oral dose form | false | Inferred relationship | Some | ||
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has precise active ingredient | Pancreatin (substance) | true | Inferred relationship | Some | 1 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Has precise active ingredient | Dehydrocholic acid (substance) | true | Inferred relationship | Some | 2 | |
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | Count of base of active ingredient | trois | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR